SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010366
Filing Date
2019-11-07
Accepted
2019-11-07 16:06:42
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20190930x10q.htm 10-Q 2043466
2 EX-31.1 kala-20190930ex311ab92c1.htm EX-31.1 22019
3 EX-31.2 kala-20190930ex312af6286.htm EX-31.2 21895
4 EX-32.1 kala-20190930ex321e82e60.htm EX-32.1 10265
5 EX-32.2 kala-20190930ex322671fd9.htm EX-32.2 10684
  Complete submission text file 0001558370-19-010366.txt   6278639

Data Files

Seq Description Document Type Size
6 EX-101.INS kala-20190930.xml EX-101.INS 1163672
7 EX-101.SCH kala-20190930.xsd EX-101.SCH 45783
8 EX-101.CAL kala-20190930_cal.xml EX-101.CAL 43452
9 EX-101.DEF kala-20190930_def.xml EX-101.DEF 141292
10 EX-101.LAB kala-20190930_lab.xml EX-101.LAB 405072
11 EX-101.PRE kala-20190930_pre.xml EX-101.PRE 288411
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 191200319
SIC: 2834 Pharmaceutical Preparations